News on this topic
Similar to This
Why Abbott Labs CEO Robert Ford is betting $2M on ABT dip | ABT
Why Abbott Labs CEO Robert Ford is betting $2M on ABT dip | ABT: Abbott Labs stock hit a 52-week low after an earnings miss, but CEO Robert Ford isn't flinching ...
thestreet.com/investing/stocks/abbott-labs-ceo-robert-ford-makes-2m-insider-buy-as-stock-sinks
Abbott bets on cancer screening with $23 billion Exact Sciences deal
Abbott bets on cancer screening with $23 billion Exact Sciences deal: Abbott will buy cancer test maker Exact Sciences in a deal valued at up to $23 billion ...
reuters.com/business/healthcare-pharmaceuticals/abbott-bolsters-diagnostics-portfolio-with-up-23-billion-buyout-exact-sciences-2025-11-20/
Abbott is weighing takeover of Exact Sciences, Bloomberg News reports
Abbott is weighing takeover of Exact Sciences, Bloomberg News reports: Medical device maker Abbott Laboratories is nearing a potential takeover of cancer test ...
reuters.com/business/healthcare-pharmaceuticals/abbott-is-weighing-takeover-exact-sciences-bloomberg-news-reports-2025-11-19/